Trial Profile
Clinical study of SM-11355 in patients with hepatocellular carcinoma (Phase III Study)
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 20 Mar 2019
Price :
$35
*
At a glance
- Drugs Epirubicin (Primary) ; Miriplatin (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- Sponsors Sumitomo Dainippon Pharma
- 31 May 2016 New trial record